|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Sucampo Pharmaceuticals Inc. (SCMP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2017-12-07 Sale |
2017-12-11 5:30 pm |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
50,000 | $16.5 | $825,000 | 242,567 (Direct) |
View |
| 2017-09-11 Sale |
2017-09-13 5:50 pm |
Sucampo Pharmaceuticals Inc. | SCMP | Ueno Ryuji 10% Owner |
1,000,000 | $12 | $12,000,000 | 8,006,585 (Indirect) |
View |
| 2017-09-11 Sale |
2017-09-13 5:50 pm |
Sucampo Pharmaceuticals Inc. | SCMP | Kuno Sachiko 10% Owner |
1,000,000 | $12 | $12,000,000 | 7,137,344 (Indirect) |
View |
| 2017-09-06 Purchase |
2017-09-08 4:40 pm |
Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer |
4,000 | $12.12 | $48,500 | 30,228 (Direct) |
View |
| 2017-08-04 Purchase |
2017-08-07 4:35 pm |
Sucampo Pharmaceuticals Inc. | SCMP | Bryan Jones W. VP |
4,700 | $10.6 | $49,820 | 4,700 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-02-13 Gift |
2018-02-14 5:50 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kuno Sachiko 10% Owner |
2,000,000 | $0 | 5,137,344 (Indirect) |
View |
| 2018-02-13 Equity Swap |
2018-02-14 5:50 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kuno Sachiko 10% Owner |
5,137,344 | $18 | 5,137,344 (Indirect) |
View |
| 2018-02-13 Gift |
2018-02-14 5:47 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Ueno Ryuji 10% Owner |
600,000 | $0 | 7,406,585 (Indirect) |
View |
| 2018-02-13 Gift |
2018-02-14 5:47 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Ueno Ryuji 10% Owner |
2,000,000 | $0 | 7,406,585 (Indirect) |
View |
| 2018-02-13 Equity Swap |
2018-02-14 5:47 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Ueno Ryuji 10% Owner |
5,406,585 | $18 | 7,406,585 (Indirect) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | OCONNELL MAUREEN Director |
5,130 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A 2023-03-01 |
Sucampo Pharmaceuticals Inc. | SCMP | OCONNELL MAUREEN Director |
30,000 | $12.81 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A 2023-05-22 |
Sucampo Pharmaceuticals Inc. | SCMP | OCONNELL MAUREEN Director |
20,000 | $9.38 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A 2024-05-09 |
Sucampo Pharmaceuticals Inc. | SCMP | OCONNELL MAUREEN Director |
20,000 | $11.2 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A 2025-05-29 |
Sucampo Pharmaceuticals Inc. | SCMP | OCONNELL MAUREEN Director |
20,000 | $1.77 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A 2027-06-01 |
Sucampo Pharmaceuticals Inc. | SCMP | OCONNELL MAUREEN Director |
10,000 | $7.7 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Walbert Timothy P Director |
5,130 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:59 pm |
N/A 2027-06-01 |
Sucampo Pharmaceuticals Inc. | SCMP | Walbert Timothy P Director |
10,000 | $7.7 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:57 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Spiegel Robert J. Director |
5,130 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:57 pm |
N/A 2025-01-16 |
Sucampo Pharmaceuticals Inc. | SCMP | Spiegel Robert J. Director |
30,000 | $3.96 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:57 pm |
N/A 2025-05-29 |
Sucampo Pharmaceuticals Inc. | SCMP | Spiegel Robert J. Director |
20,000 | $1.77 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:57 pm |
N/A 2027-06-01 |
Sucampo Pharmaceuticals Inc. | SCMP | Spiegel Robert J. Director |
10,000 | $7.7 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:56 pm |
N/A 2027-07-15 |
Sucampo Pharmaceuticals Inc. | SCMP | Smith Karen L. Director |
30,000 | $7.05 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Edick Paul R Director |
14,930 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2027-06-01 |
Sucampo Pharmaceuticals Inc. | SCMP | Edick Paul R Director |
10,000 | $7.7 | 0 (Direct) |
View |
| 2018-02-13 Option Award |
2018-02-13 4:54 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
36,975 | $18 | 36,975 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2024-06-09 |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
150,000 | $10.6 | 36,975 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2024-09-11 |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
25,000 | $11.25 | 36,975 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2025-03-04 |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
28,000 | $3.18 | 36,975 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2026-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
75,000 | $4.2 | 36,975 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2027-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
101,000 | $6.15 | 36,975 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
129,729 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2024-03-03 |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
600,000 | $9.51 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2024-07-31 |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
200,000 | $12.1 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2025-03-04 |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
210,000 | $3.18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2026-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
420,000 | $4.2 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:54 pm |
N/A 2027-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
237,000 | $6.15 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:52 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | JOHNSON JOHN Director |
5,130 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:52 pm |
N/A 2024-12-10 |
Sucampo Pharmaceuticals Inc. | SCMP | JOHNSON JOHN Director |
30,000 | $4.08 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:52 pm |
N/A 2025-05-29 |
Sucampo Pharmaceuticals Inc. | SCMP | JOHNSON JOHN Director |
20,000 | $1.77 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:52 pm |
N/A 2025-05-29 |
Sucampo Pharmaceuticals Inc. | SCMP | JOHNSON JOHN Director |
10,000 | $7.7 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:51 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
44,856 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:51 pm |
N/A 2024-10-27 |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
250,000 | $9.67 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:51 pm |
N/A 2025-03-04 |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
38,500 | $3.18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:51 pm |
N/A 2026-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
87,203 | $4.2 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:51 pm |
N/A 2027-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
133,000 | $6.15 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
24,000 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A 2021-06-01 |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
78,200 | $13.73 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A 2024-07-01 |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
78,200 | $10.83 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A 2024-09-11 |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
25,000 | $11.25 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A 2025-03-04 |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
44,000 | $3.18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A 2026-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
44,000 | $4.2 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:48 pm |
N/A 2027-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Lichtlen Peter Chief Medical Officer |
45,000 | $6.15 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:47 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | PFREUNDSCHUH PETER P. CFO |
263 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:47 pm |
N/A 2027-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | PFREUNDSCHUH PETER P. CFO |
150,000 | $7.1 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:44 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Bryan Jones W. VP |
5,139 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:44 pm |
N/A 2027-03-20 |
Sucampo Pharmaceuticals Inc. | SCMP | Bryan Jones W. VP |
150,000 | $7.1 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:41 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer |
30,228 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:41 pm |
N/A 2027-04-03 |
Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer |
150,000 | $7.35 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:41 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
6,084 | $18 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:41 pm |
N/A 2025-05-18 |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
25,600 | $1.96 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:41 pm |
N/A 2026-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
24,150 | $4.2 | 0 (Direct) |
View |
| 2018-02-13 Disposition |
2018-02-13 4:41 pm |
N/A 2027-03-02 |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
11,068 | $6.15 | 0 (Direct) |
View |
| 2017-09-30 Option Award |
2018-01-12 6:05 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | PFREUNDSCHUH PETER P. CFO |
131 | $9.1 | 263 (Direct) |
View |
| 2017-09-30 Option Award |
2018-01-12 6:05 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | PFREUNDSCHUH PETER P. CFO |
263 | $9.1 | 263 (Direct) |
View |
| 2017-12-31 Option Award |
2018-01-12 4:36 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Bryan Jones W. VP |
439 | $10.24 | 5,139 (Direct) |
View |
| 2017-12-31 Option Award |
2018-01-04 5:16 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
171 | $9.1 | 4,792 (Direct) |
View |
| 2017-12-31 Option Award |
2018-01-04 5:16 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
329 | $9.1 | 44,856 (Direct) |
View |
| 2017-12-31 Option Award |
2018-01-04 5:15 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
330 | $9.1 | 36,975 (Direct) |
View |
| 2017-12-31 Option Award |
2018-01-04 5:15 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
660 | $9.1 | 6,084 (Direct) |
View |
| 2017-12-28 Tax Withholding |
2018-01-02 5:00 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
27,496 | $17.98 | 44,527 (Direct) |
View |
| 2017-12-28 Tax Withholding |
2018-01-02 4:58 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
19,353 | $17.98 | 36,645 (Direct) |
View |
| 2017-12-28 Tax Withholding |
2018-01-02 4:56 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
2,025 | $17.98 | 5,424 (Direct) |
View |
| 2017-12-07 Exercise |
2017-12-11 5:30 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
50,000 | $8.33 | 242,567 (Direct) |
View |
| 2017-12-07 Exercise |
2017-12-11 5:30 pm |
N/A 2024-10-27 |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
50,000 | $8.33 | 242,567 (Direct) |
View |
| 2017-09-30 Option Award |
2017-10-05 4:40 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Kiener Peter A Chief Science Officer |
330 | $9.1 | 2,023 (Direct) |
View |
| 2017-09-30 Option Award |
2017-10-05 4:37 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Donley Matthew Maxwell VP |
330 | $9.1 | 2,998 (Direct) |
View |
| 2017-09-30 Option Award |
2017-10-05 4:35 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Driggs Alex General Counsel & Corp. Sec. |
659 | $9.1 | 1,331 (Direct) |
View |
| 2017-09-30 Option Award |
2017-10-05 4:32 pm |
N/A N/A |
Sucampo Pharmaceuticals Inc. | SCMP | Greenleaf Peter CEO |
659 | $9.1 | 4,621 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 21 Jul 2019 18:55:33 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |